Singapore Patent Agents QE Paper D Practice Questions - Singapore Patent Agents Qualifying Examination Paper D - Patent Law & Practice Exam - Singapore Patent Agents QE Paper D Practice Questions - Singapore Patent Agents Qualifying Examination Paper D

Question 1

Under Section 14(2) of the Singapore Patents Act (Cap 221), which of the following is considered part of the 'state of the art' for the purpose of assessing the novelty of an invention?

Any matter made available to the public in Singapore or elsewhere by written or oral description, by use, or in any other way before the priority date. Only written descriptions published in registered patent journals in Singapore before the filing date. Any oral disclosure made anywhere in the world, provided it was recorded and published in writing before the priority date. Only matter that was publicly used or known within the territory of Singapore before the priority date.

Correct Answer:

Any matter made available to the public in Singapore or elsewhere by written or oral description, by use, or in any other way before the priority date.

Question 2

In Singapore, can a pending but unpublished Singapore patent application with an earlier priority date be used to challenge the novelty and inventive step of a subsequent patent application?

It can be used to challenge the novelty of the subsequent application under Section 14(3), but it is disregarded for the purpose of assessing inventive step under Section 15. It can be used to challenge both the novelty under Section 14(3) and the inventive step under Section 15 of the subsequent application. It cannot be used for either novelty or inventive step because it was not published at the priority date of the subsequent application. It can only be used if the applicant of the subsequent application had actual knowledge of the earlier unpublished application.

Correct Answer:

It can be used to challenge the novelty of the subsequent application under Section 14(3), but it is disregarded for the purpose of assessing inventive step under Section 15.

Question 3

Under the Patents Act, if an inventor discloses their invention publicly on 1 June 2025 and subsequently files a Singapore patent application on 1 March 2026, how is this prior disclosure treated during examination?

It is excluded from the state of the art under Section 14(4) because it was disclosed by the inventor within the 12-month grace period before the filing date. It destroys the novelty of the application because Singapore does not provide a grace period for voluntary disclosures by the inventor. It is only excluded from the state of the art if the disclosure was made in breach of a confidentiality agreement by a third party. It is excluded from the state of the art only if the applicant files a petition and pays a penalty fee for late filing.

Correct Answer:

It is excluded from the state of the art under Section 14(4) because it was disclosed by the inventor within the 12-month grace period before the filing date.

Question 4

Which of the following claim formulations is NOT deemed capable of industrial application under Section 16(2) of the Singapore Patents Act?

A method of diagnosing diabetes mellitus practiced directly on the human body. A diagnostic kit containing test strips and reagents for detecting blood glucose levels. A process for manufacturing a pharmaceutical compound for treating diabetes. A surgical scalpel coated with an antimicrobial polymer.

Correct Answer:

A method of diagnosing diabetes mellitus practiced directly on the human body.

Question 5

How are 'second medical use' claims for known substances or compositions evaluated and drafted under current IPOS practice?

Both Swiss-type claims ('Use of X in the manufacture of a medicament...') and EPC 2000 claims ('X for use in the treatment of...') are accepted and recognized as novel and industrially applicable. Only Swiss-type claims are accepted; EPC 2000 claims are rejected as lacking industrial applicability under Section 16(2). Only EPC 2000 claims are accepted; Swiss-type claims are rejected as being directed to an unpatentable method of manufacture. Second medical use claims are completely prohibited in Singapore as they are deemed to lack novelty over the first medical use.

Correct Answer:

Both Swiss-type claims ('Use of X in the manufacture of a medicament...') and EPC 2000 claims ('X for use in the treatment of...') are accepted and recognized as novel and industrially applicable.

Question 1

Exam overview

About this Exam

Prepare with the Singapore Patent Agents QE Paper D Practice Questions - Singapore Patent Agents Qualifying Examination Paper D - Patent Law & Practice Exam practice quiz. This question bank includes 100 questions covering patent, singapore, application, section, and patents. Use it to review important concepts, identify knowledge gaps, and build confidence for the related exam, course, or assessment.

More details

Additional Information

Singapore Patent Agents QE Paper D Practice Questions - Singapore Patent Agents Qualifying Examination Paper D - Patent Law & Practice Exam

This practice set contains 100 questions from the matching question bank and focuses on patent, singapore, application, section, and patents. Work through each question carefully, review the provided solutions, and revisit topics that need more study before your next attempt.

This is an independent study resource intended for practice and review; it is not an official examination or an endorsement by any organization named in the title.

Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.

No fixed duration is currently configured for this quiz.

Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.

Yes. You can retake the practice test again as you continue studying during your available access period.

After your access is confirmed, you can continue into the complete practice exam from this quiz flow.

Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.

Keep studying

Correct Answer:

Correct Answer:

Correct Answer:

Correct Answer:

Correct Answer:

About this Exam

Additional Information

Singapore Patent Agents QE Paper D Practice Questions - Singapore Patent Agents Qualifying Examination Paper D - Patent Law & Practice Exam

Frequently Asked Questions

Related Questions

43-Hour Federal Qualifying Education Practice Test

Ultimate Architect Registration Examination ARE Practice Exam

AAPD Qualifying Examination QE Practice Exam

Objective Structured Clinical Examination (OSCE) Practice Exam

CDCA Objective Structured Clinical Examination (OSCE) Practice Exam

SCE) Practice ExCDCA Objective Structured Clinical Examination (Oam